-
1 Comment
EMvision Medical Devices Limited is currently in a long term downtrend where the price is trading 2.9% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
EMvision Medical Devices Limited's total revenue sank by 17.2% to $389K since the same quarter in the previous year.
Its net income has dropped by 77.9% to $-3M since the same quarter in the previous year.
Finally, its free cash flow grew by 39.6% to $-530K since the same quarter in the previous year.
Based on the above factors, EMvision Medical Devices Limited gets an overall score of 2/5.
| Sector | Healthcare |
|---|---|
| ISIN | AU0000028375 |
| Exchange | AU |
| CurrencyCode | AUD |
| Industry | Medical Devices |
| Market Cap | 161M |
|---|---|
| Beta | 1.27 |
| PE Ratio | None |
| Target Price | 2.3 |
| Dividend Yield | None |
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. The company offers non-invasive brain scanners bedside device emu, an ultra-light weight first responder pre-hospital device. EMVision Medical Devices Ltd was incorporated in 2017 and is based in Macquarie Park, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EMV.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
